drugset / Trial / NCT06416865
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-blind, Multi-center, Phase III study to evaluate the efficacy and safety of the AJU-C52 compared with the combination of C52R1M in patients with essential Hypertension Patients who have inappropriately controlled on C52R1L treament
Timeline
- Start
- 2022-06-27
- Primary completion
- 2022-12-12
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AJU-C52 | Unknown | — | — |
| Subject | AJU-C52L | Unknown | — | — |
| Subject | C52R1L | Unknown | — | — |
| Subject | C52R1M | Unknown | — | — |